CAPTRUST Financial Advisors
PCRX icon

CAPTRUST Financial Advisors’s Pacira BioSciences PCRX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,219
Closed -$210K – 2509
2023
Q4 		$210K Buy
+6,219
New +$182K ﹤0.01% 2367
2022
Q4 		– Sell
-4,185
Closed -$223K – 2153
2022
Q3 		$223K Sell
4,185
-5,537
-57% -$308K ﹤0.01% 1750
2022
Q2 		$567K Sell
9,722
-2,313
-19% -$152K ﹤0.01% 1094
2022
Q1 		$919K Buy
12,035
+9,499
+375% +$633K 0.01% 882
2021
Q4 		$153K Buy
2,536
+99
+4% +$5.46K ﹤0.01% 1837
2021
Q3 		$136K Sell
2,437
-687
-22% -$39.6K ﹤0.01% 1833
2021
Q2 		$190K Sell
3,124
-4,801
-61% -$304K ﹤0.01% 1560
2021
Q1 		$555K Buy
7,925
+3,620
+84% +$259K 0.01% 924
2020
Q4 		$258K Buy
4,305
+367
+9% +$21.5K ﹤0.01% 1093
2020
Q3 		$236K Buy
3,938
+431
+12% +$25K ﹤0.01% 966
2020
Q2 		$186K Buy
3,507
+647
+23% +$27K ﹤0.01% 1065
2020
Q1 		$92K Buy
+2,860
New +$119K ﹤0.01% 1160
2018
Q2 		– Sell
-15
Closed – – 1582
2018
Q1 		$0 Buy
+15
New +$534 ﹤0.01% 1363

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CAPTRUST Financial Advisors's PCRX Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Pacira BioSciences (PCRX) in Q1 2024, closing a stake of 6,219 shares — an estimated $210K sold.

CAPTRUST Financial Advisors first reported a position in PCRX in Q1 2018 and held it in 13 quarters. The position peaked at $919K in Q1 2022. 270 funds tracked by Wall St. Rank hold PCRX as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Pacira BioSciences position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 6,219 Pacira BioSciences shares in Q1 2024, an estimated $210K.
  • CAPTRUST Financial Advisors first reported a position in Pacira BioSciences in Q1 2018 and held it in 13 quarters.
  • CAPTRUST Financial Advisors's Pacira BioSciences position peaked at $919K in Q1 2022.
  • 270 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.